Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business
| GELS Stock | 1.86 0.05 2.76% |
Slightly above 51% of Gelteq Limited's investor base is interested to short. The analysis of overall sentiment of trading Gelteq Limited Ordinary stock suggests that many investors are impartial at this time. Gelteq Limited's investing sentiment can be driven by a variety of factors including economic data, Gelteq Limited's earnings reports, geopolitical events, and overall market trends.
Gelteq |
NEW YORK, Nov. 12, 2024 -- Gelteq Limited , a clinical and science-based company that is...
Read at globenewswire.com
 |
Gelteq Limited Fundamental Analysis
We analyze Gelteq Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gelteq Limited using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gelteq Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Gelteq Limited is rated # 4 in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Gelteq Limited Ordinary Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gelteq Limited stock to make a market-neutral strategy. Peer analysis of Gelteq Limited could also be used in its relative valuation, which is a method of valuing Gelteq Limited by comparing valuation metrics with similar companies.
Peers
Gelteq Limited Related Equities
| IMCC | Im Cannabis | 51.23 | ||||
| GELS | Gelteq Limited | 2.76 | ||||
| INDV | Indivior PLC | 1.34 | ||||
| TAK | Takeda Pharmaceutical | 0.97 | ||||
| EBS | Emergent Biosolutions | 0.80 | ||||
| ZTS | Zoetis | 0.59 | ||||
| HROW | Harrow Health | 0.54 | ||||
| YCBD | CbdMD | 3.92 | ||||
| UPC | Universe Pharmaceuticals | 4.97 | ||||
| YCBD-PA | CbdMD | 8.00 |
Additional Tools for Gelteq Stock Analysis
When running Gelteq Limited's price analysis, check to measure Gelteq Limited's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gelteq Limited is operating at the current time. Most of Gelteq Limited's value examination focuses on studying past and present price action to predict the probability of Gelteq Limited's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gelteq Limited's price. Additionally, you may evaluate how the addition of Gelteq Limited to your portfolios can decrease your overall portfolio volatility.